Cboe Global Markets, Inc. (CBOE) Stock Price & How to Invest

Cboe Global Markets operates a family of exchanges spanning options, North American equities, European and Asia-Pacific markets, futures, and global FX, and it earns money primarily from transaction fees, market data, and access services. Its crown jewel is the proprietary volatility franchise: the VIX index, VIX futures and options, and SPX index options are exclusively listed on Cboe venues, giving it a durable niche that rivals cannot easily replicate. The Data Vantage segment (market data and analytics) adds a recurring, subscription-like revenue stream on top of the more volume-sensitive transaction business.

The investment picture is that of a high-margin financial-infrastructure toll taker whose results scale with trading activity and market volatility. Cboe posted record net revenue of roughly $729 million in Q1 2026 (up about 29 percent year over year) with adjusted diluted EPS near $3.70, and full-year 2025 total revenue of about $4.7 billion, reflecting strong options and derivatives demand. It carries a premium valuation (trailing P/E near 27x) that reflects its moat and consistency, while the main debates center on whether elevated volatility-driven volumes are sustainable and on emerging competitive threats to its derivatives franchise.

Cboe's transaction revenue is tied to trading volumes and market volatility, so a prolonged calm, low-volume market environment can pressure its most profitable options and VIX products. Emerging competitors and new instruments, including crypto perpetual-futures venues like Kalshi that regulators have begun to approve, could siphon derivatives flow over time, a risk analysts flag as most acute for Cboe among the major exchange operators. Regulatory changes affecting market structure, fees, or market-data pricing represent an ongoing overhang for all exchanges. The premium valuation leaves limited room for error if volume growth normalizes. Concentration in a handful of index and volatility products means any competitive or structural erosion there would matter disproportionately.

14 analysts publish price targets on CBOE, averaging $314.00 against a $310.23 price as of August 2026, or +1.2%. The published targets run from $258.00 to $380.00, a moderate spread, and the ratings split 3 buy, 11 hold, 3 sell. Over the last six months there have been 9 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CBOE forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Cboe Global Markets, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Proprietary volatility and index-options franchise. Cboe holds exclusive listing rights to the VIX complex and SPX index options, which generate high-margin, recurring transaction revenue that competitors cannot directly replicate. The most optimistic published target, $380.00, assumes this works close to its best case.

The case against. Cboe's transaction revenue is tied to trading volumes and market volatility, so a prolonged calm, low-volume market environment can pressure its most profitable options and VIX products. The most pessimistic target, $258.00, is roughly what CBOE is worth if this bites instead.

Read the full bull and bear case on CBOE, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Cboe Global Markets, Inc.'s investor relations page or your broker.

• Net revenue (Q1 2026): ~$729M (+29% YoY)
• Total revenue (FY2025): ~$4.7B
• Adjusted diluted EPS (Q1 2026): ~$3.70 (+48% YoY)
• Net income (Q1 2026): ~$386M
• Market cap: ~$28B
• Trailing P/E: ~27x
• Dividend yield: ~1.0%

Cboe reported record Q1 2026 net revenue of roughly $729 million and adjusted EPS near $3.70, both well above analyst expectations, on strength in options and volatility products. Full-year 2025 delivered about 17 percent net revenue growth and strong EPS gains. The stock trades at a premium P/E in the high-20s, consistent with its moat and steady cash generation but leaving little margin for a volume slowdown.

Other names that sit close to CBOE: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CBOE exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CBOE sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CBOE fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Cboe is a wide-moat derivatives-exchange operator whose earnings ride on options and volatility trading activity, priced as a steady infrastructure compounder rather than a bargain.

Whether CBOE is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CBOE a buy or a sell?, and where the stock could go from here in the CBOE stock forecast.

For income investors, whether CBOE pays a dividend and how the payout looks is covered in does CBOE pay a dividend? And to weigh CBOE against a peer, read the full side-by-side comparisons: CBOE vs CME and CBOE vs ICE.